(Q37450852)

20 August 2017

Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia (English)

1 reference

20 August 2017

1 reference

human papillomavirus 16

1 reference

Gina S Ogilvie

10

0 references

Mel Krajden

1

object named as

Mel Krajden

1 reference

20 August 2017

2

Karuna Karunakaran

1 reference

20 August 2017

11

Martin Petric

1 reference

20 August 2017

8

Ron Chow

1 reference

20 August 2017

Stacy So

3

1 reference

20 August 2017

Joel M Palefsky

4

1 reference

20 August 2017

Rachna Sharma

5

1 reference

20 August 2017

Darrel Cook

6

1 reference

20 August 2017

Amanda Yu

7

1 reference

20 August 2017

Simon Dobson

9

1 reference

20 August 2017

14 October 2009

1 reference

Clinical and Vaccine Immunology

20 August 2017

1 reference

20 August 2017

16

1 reference

20 August 2017

12

1 reference

20 August 2017

1840-1843

1 reference

Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Measurement of the humoral immune response following an incident human papillomavirus type 16 or 18 infection in young women by a pseudovirion-based neutralizing antibody assay

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroprevalence of 34 human papillomavirus types in the German general population

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Generation of HPV pseudovirions using transfection and their use in neutralization assays.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vacc

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroepidemiology as basis for design of a human papillomavirus vaccination program.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19828766

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/CVI.00238-09

1 reference

release_7ialnskfbzg2toduvnv5yitjvu

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ialnskfbzg2toduvnv5yitjvu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

20 August 2017

PubMed publication ID

19828766

1 reference